Terns Pharmaceuticals (TERN) Tax Provisions (2020 - 2023)
Historic Tax Provisions for Terns Pharmaceuticals (TERN) over the last 4 years, with Q4 2023 value amounting to $68000.0.
- Terns Pharmaceuticals' Tax Provisions fell 7861.64% to $68000.0 in Q4 2023 from the same period last year, while for Dec 2023 it was $258000.0, marking a year-over-year decrease of 2793.3%. This contributed to the annual value of $554000.0 for FY2024, which is 11472.87% up from last year.
- Latest data reveals that Terns Pharmaceuticals reported Tax Provisions of $68000.0 as of Q4 2023, which was down 7861.64% from $58000.0 recorded in Q3 2023.
- In the past 5 years, Terns Pharmaceuticals' Tax Provisions registered a high of $711000.0 during Q4 2020, and its lowest value of $6000.0 during Q2 2022.
- Over the past 4 years, Terns Pharmaceuticals' median Tax Provisions value was $59000.0 (recorded in 2023), while the average stood at $138357.1.
- In the last 5 years, Terns Pharmaceuticals' Tax Provisions crashed by 8039.22% in 2021 and then skyrocketed by 110000.0% in 2023.
- Over the past 4 years, Terns Pharmaceuticals' Tax Provisions (Quarter) stood at $711000.0 in 2020, then crashed by 38.82% to $435000.0 in 2021, then decreased by 26.9% to $318000.0 in 2022, then crashed by 78.62% to $68000.0 in 2023.
- Its Tax Provisions stands at $68000.0 for Q4 2023, versus $58000.0 for Q3 2023 and $72000.0 for Q2 2023.